Insider Transactions in Q2 2024 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,019
-5.81%
|
$24,057
$3.5 P/Share
|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,473
+14.01%
|
-
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,327
-14.33%
|
$57,981
$3.47 P/Share
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,167
+28.66%
|
-
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,920
-5.52%
|
$26,760
$3.47 P/Share
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+13.39%
|
-
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,900
-31.6%
|
$23,700
$3.47 P/Share
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|